speb/financial-data huggingface dataset:
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 115700000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 115700000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 60100000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 23000000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 4370500000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1099300000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Other Payable: 82063000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 82063000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Other Properties: 22350000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 22350000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 280072000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 280072000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 287500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 287500000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Other Special Charges: 11931000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Payables: 2324889000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Payables: 2324889000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 41204000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 41204000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 604834000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 604834000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Pretax Income: 193600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 45600000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -739300000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 1346591000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1346591000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 8467800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2017200000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 620100000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 158800000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 11089000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 11089000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 135518000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 135518000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 2783094000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2783094000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 2400000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 186175000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Share Issued: 58499091.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 58499091.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Special Income Charges: -11931000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: -11931000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 5200000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 5776345000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5776345000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 5775378000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5775378000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Tax Provision: 77300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 25400000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.40
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -34300000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Total Assets: 10309159000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 10309159000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 6265173000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 6265173000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Total Debt: 2017876000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 2017876000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 5776345000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5776345000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Total Expenses: 14328800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 3498000000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 4532814000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4532814000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 5290500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 5290500000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 662421000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 662421000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 172825000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 332000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 332000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -11931000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -11931000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -11931000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -11931000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Work In Process: 165312000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 165312000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Working Capital: 1148266000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 1148266000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1524500000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 3264800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 58360656.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Basic EPS: -0.61
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1741000000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 167400000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 167400000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 58360656.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.61
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -35600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — EBIT: 20300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — EBITDA: 187700000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 1523800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 75900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 75900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Net Income: -35600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -35600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -35600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -35600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -35600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -35600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -75900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -75900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 187700000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Normalized Income: -35600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Operating Income: -700000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 3264800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 21000000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1122700000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Pretax Income: -55600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1741000000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 167400000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Tax Provision: -20000000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.36
AYMSYNTEX.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 3265500000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1604700000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 3491500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2329100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1316300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 85100000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 65000000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Basic EPS: -0.06
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 133600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 585800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 32600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 301600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 585800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 5748700000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 612900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1858500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 4942700000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 72800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 1725500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1798300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 4369400000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 165900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 165900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 65000000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.06
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -3900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — EBIT: 77500000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — EBITDA: 243400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 700000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 5403300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 1633000000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 83100000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 83100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 2640300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 7997100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 85100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 60800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 522900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 583700000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 2215800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Net Income: -3900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -3900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -3900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -3900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -3900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -3900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -83100000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -83100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 5403300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 5748000000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 187600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 71000000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 243400000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Normalized Income: -3900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Operating Income: 28300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 3491500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 58581091.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 677200000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 33900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 125400000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 49200000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1192600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 4790400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 7300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 269000000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Payables: 2329400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 92100000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Pretax Income: -5600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1858500000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 165900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 58581091.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 5748700000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 5748000000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Tax Provision: -1700000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 10772800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 6271600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 2382000000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5748700000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 3463200000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 5024100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 5830100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 654700000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 573300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1486100000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 3237200000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 59200000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.25
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1657300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 140400000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 140400000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 59200000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.25
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 14800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — EBIT: 106700000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — EBITDA: 247100000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1579900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 83600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 83600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Net Income: 14800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 14800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 14800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 14800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 14800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 14800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -83600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -83600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 247100000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 14800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Operating Income: 93800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 3237200000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 12900000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1114600000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 23100000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1657300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 140400000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 8300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.36
AYMSYNTEX.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 3143400000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — +Operating Expense: 5834500000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1532300000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — +Total Revenue: 13651200000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 3657700000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 2560200000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2560200000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1339400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1339400000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 52100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 52100000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 58482143.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 58571429.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Basic EPS: 1.12
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 1.54
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 181700000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1226200000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 98400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 98400000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 586100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 586100000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 47300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 47300000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 402900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 402900000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 132100000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 34900000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -4200000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Change In Payable: 322900000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -60900000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 448600000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -134400000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Common Stock: 586100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 586100000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 5885500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 5885500000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 1200000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 416100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 416100000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 7505400000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1935500000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Current Assets: 4763800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 4763800000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 73800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 73800000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Current Debt: 1220600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 1220600000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1294400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1294400000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 4156900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4156900000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Depreciation: 616900000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 616900000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 616900000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 143200000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 616900000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 143200000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 58482143.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 58571429.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Diluted EPS: 1.12
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.54
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 65500000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 90200000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — EBIT: 416400000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — EBIT: 211900000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — EBITDA: 1033300000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — EBITDA: 355100000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — End Cash Position: 47300000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -451500000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 285500000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: 23800000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 1000000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 500000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 5670400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 5670400000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Gross Profit: 6145800000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1722200000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Interest Expense: 320200000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 77600000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 320200000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 77600000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -313000000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 10100000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Inventory: 2373300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 2373300000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 7665400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 7665400000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1194600000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 52100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 52100000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 1200000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 24600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 24600000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 559300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 559300000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 583900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 583900000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 1200000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Net Debt: 1732600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 1732600000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -13400000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Net Income: 65500000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Net Income: 90200000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 65500000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 90200000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 65500000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 90200000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 65500000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 90200000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 65500000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 90200000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 96200000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 65500000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 90200000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Net Interest Income: -320200000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -77600000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 17600000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 169200000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -19900000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -320200000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -77600000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -240000000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Net PPE: 5670400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 5670400000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -1222300000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 189100000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 5885000000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5885000000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 153600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 153600000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 91000000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 91000000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1033300000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 355100000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Normalized Income: 65500000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 90200000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1511700000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Operating Income: 311300000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Operating Income: 189900000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Operating Revenue: 13651200000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 3657700000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 58614091.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 58614091.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 644200000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 644200000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 61400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 61400000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 309500000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 68100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 68100000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 105100000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 22000000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 4261200000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1144400000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Other Properties: 5254300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 5254300000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 4000000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 4000000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 355600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 355600000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Payables: 2560200000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Payables: 2560200000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 73600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 73600000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Pretax Income: 96200000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 134300000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1226200000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 7505400000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1935500000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 616900000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 143200000.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 3900000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Share Issued: 58614091.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 58614091.00
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 40200000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 5885500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5885500000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 5885000000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5885000000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Tax Provision: 30700000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 44100000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.32
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.33
AYMSYNTEX.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -11100000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Total Assets: 10717300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 10717300000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 6444800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 6444800000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Total Debt: 1878300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 1878300000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 5885500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5885500000.00
AYMSYNTEX.NS income_statement (annual, 2026-03-31) — Total Expenses: 13339900000.00
AYMSYNTEX.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 3467800000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 4831800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4831800000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 5953500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 5953500000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 674900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 674900000.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 0.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
AYMSYNTEX.NS balance_sheet (annual, 2026-03-31) — Working Capital: 606900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 606900000.00
AYT.AX income_statement (annual, 2021-06-30) — +Operating Expense: 1049055.00
AYT.AX balance_sheet (annual, 2021-06-30) — Accounts Payable: 31535.00
AYT.AX balance_sheet (annual, 2021-06-30) — Accounts Receivable: 337.00
AYT.AX income_statement (annual, 2021-06-30) — Basic Average Shares: 488819822.00
AYT.AX income_statement (annual, 2021-06-30) — Basic EPS: 0.00
AYT.AX cash_flow (annual, 2021-06-30) — Beginning Cash Position: 650725.00
AYT.AX cash_flow (annual, 2021-06-30) — Capital Expenditure: -410115.00
AYT.AX cash_flow (annual, 2021-06-30) — Capital Expenditure Reported: -410115.00
AYT.AX balance_sheet (annual, 2021-06-30) — Capital Stock: 22018334.00
AYT.AX balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 2288432.00
AYT.AX balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 2288432.00
AYT.AX balance_sheet (annual, 2021-06-30) — Cash Equivalents: 2185596.00
AYT.AX balance_sheet (annual, 2021-06-30) — Cash Financial: 102836.00
AYT.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Financing Activities: 2560220.00
AYT.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Investing Activities: -405615.00
AYT.AX cash_flow (annual, 2021-06-30) — Cash Flowsfromusedin Operating Activities Direct: -516898.00
AYT.AX cash_flow (annual, 2021-06-30) — Changes In Cash: 1637707.00
AYT.AX cash_flow (annual, 2021-06-30) — Classesof Cash Payments: -559251.00
AYT.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 35500.00
AYT.AX balance_sheet (annual, 2021-06-30) — Common Stock: 22018334.00
AYT.AX balance_sheet (annual, 2021-06-30) — Common Stock Equity: 8357008.00
AYT.AX cash_flow (annual, 2021-06-30) — Common Stock Issuance: 2572746.00
AYT.AX cash_flow (annual, 2021-06-30) — Common Stock Payments: -12526.00
AYT.AX balance_sheet (annual, 2021-06-30) — Current Assets: 2345290.00
AYT.AX balance_sheet (annual, 2021-06-30) — Current Liabilities: 75863.00
AYT.AX income_statement (annual, 2021-06-30) — Depreciation Amortization Depletion Income Statement: 3166.00
AYT.AX income_statement (annual, 2021-06-30) — Depreciation And Amortization In Income Statement: 3166.00
AYT.AX income_statement (annual, 2021-06-30) — Depreciation Income Statement: 3166.00
AYT.AX income_statement (annual, 2021-06-30) — Diluted Average Shares: 488819822.00
AYT.AX income_statement (annual, 2021-06-30) — Diluted EPS: 0.00
AYT.AX income_statement (annual, 2021-06-30) — EBIT: -1049055.00
AYT.AX income_statement (annual, 2021-06-30) — EBITDA: -1045889.00
AYT.AX cash_flow (annual, 2021-06-30) — End Cash Position: 2288432.00
AYT.AX cash_flow (annual, 2021-06-30) — Financing Cash Flow: 2560220.00
AYT.AX balance_sheet (annual, 2021-06-30) — Foreign Currency Translation Adjustments: -5638.00
AYT.AX cash_flow (annual, 2021-06-30) — Free Cash Flow: -927013.00
AYT.AX balance_sheet (annual, 2021-06-30) — Gains Losses Not Affecting Retained Earnings: 2121.00
AYT.AX income_statement (annual, 2021-06-30) — General And Administrative Expense: 265437.00
AYT.AX balance_sheet (annual, 2021-06-30) — Gross PPE: 5911302.00
AYT.AX income_statement (annual, 2021-06-30) — Interest Income: 6853.00
AYT.AX income_statement (annual, 2021-06-30) — Interest Income Non Operating: 6853.00
AYT.AX cash_flow (annual, 2021-06-30) — Interest Received Direct: 6853.00
AYT.AX balance_sheet (annual, 2021-06-30) — Invested Capital: 8357008.00
AYT.AX cash_flow (annual, 2021-06-30) — Investing Cash Flow: -405615.00
AYT.AX balance_sheet (annual, 2021-06-30) — Investments And Advances: 175500.00
AYT.AX cash_flow (annual, 2021-06-30) — Issuance Of Capital Stock: 2572746.00
AYT.AX cash_flow (annual, 2021-06-30) — Net Common Stock Issuance: 2560220.00
AYT.AX income_statement (annual, 2021-06-30) — Net Income: -997375.00
AYT.AX income_statement (annual, 2021-06-30) — Net Income Common Stockholders: -997375.00
AYT.AX income_statement (annual, 2021-06-30) — Net Income Continuous Operations: -997375.00
AYT.AX income_statement (annual, 2021-06-30) — Net Income From Continuing And Discontinued Operation: -997375.00
AYT.AX income_statement (annual, 2021-06-30) — Net Income From Continuing Operation Net Minority Interest: -997375.00
AYT.AX income_statement (annual, 2021-06-30) — Net Income Including Noncontrolling Interests: -997375.00
AYT.AX income_statement (annual, 2021-06-30) — Net Interest Income: 6853.00
AYT.AX cash_flow (annual, 2021-06-30) — Net Investment Purchase And Sale: -15500.00
AYT.AX income_statement (annual, 2021-06-30) — Net Non Operating Interest Income Expense: 6853.00
AYT.AX balance_sheet (annual, 2021-06-30) — Net PPE: 5911302.00
AYT.AX cash_flow (annual, 2021-06-30) — Net PPE Purchase And Sale: 20000.00
AYT.AX balance_sheet (annual, 2021-06-30) — Net Tangible Assets: 8357008.00
AYT.AX balance_sheet (annual, 2021-06-30) — Non Current Accounts Receivable: 779.00
AYT.AX income_statement (annual, 2021-06-30) — Normalized EBITDA: -1045889.00
AYT.AX income_statement (annual, 2021-06-30) — Normalized Income: -997375.00
AYT.AX income_statement (annual, 2021-06-30) — Operating Income: -1049055.00
AYT.AX balance_sheet (annual, 2021-06-30) — Ordinary Shares Number: 561078103.00
AYT.AX cash_flow (annual, 2021-06-30) — Other Cash Receiptsfrom Operating Activities: 35500.00
AYT.AX balance_sheet (annual, 2021-06-30) — Other Equity Adjustments: 7759.00
AYT.AX income_statement (annual, 2021-06-30) — Other Gand A: 193095.00
AYT.AX income_statement (annual, 2021-06-30) — Other Income Expense: 44827.00
AYT.AX balance_sheet (annual, 2021-06-30) — Other Investments: 175500.00
AYT.AX income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: 44827.00
AYT.AX income_statement (annual, 2021-06-30) — Other Operating Expenses: 780452.00
AYT.AX balance_sheet (annual, 2021-06-30) — Other Payable: 44328.00
AYT.AX balance_sheet (annual, 2021-06-30) — Other Properties: 5911302.00
AYT.AX balance_sheet (annual, 2021-06-30) — Other Receivables: 39854.00
AYT.AX balance_sheet (annual, 2021-06-30) — Payables: 75863.00
AYT.AX balance_sheet (annual, 2021-06-30) — Payables And Accrued Expenses: 75863.00
AYT.AX cash_flow (annual, 2021-06-30) — Paymentsto Suppliersfor Goodsand Services: -559251.00
AYT.AX balance_sheet (annual, 2021-06-30) — Prepaid Assets: 16667.00
AYT.AX income_statement (annual, 2021-06-30) — Pretax Income: -997375.00
AYT.AX cash_flow (annual, 2021-06-30) — Purchase Of Investment: -15500.00
AYT.AX balance_sheet (annual, 2021-06-30) — Receivables: 40191.00
AYT.AX income_statement (annual, 2021-06-30) — Reconciled Depreciation: 3166.00
AYT.AX income_statement (annual, 2021-06-30) — Rent And Landing Fees: 2346.00
AYT.AX cash_flow (annual, 2021-06-30) — Repurchase Of Capital Stock: -12526.00
AYT.AX balance_sheet (annual, 2021-06-30) — Retained Earnings: -13663447.00
AYT.AX income_statement (annual, 2021-06-30) — Salaries And Wages: 69996.00
AYT.AX cash_flow (annual, 2021-06-30) — Sale Of PPE: 20000.00
AYT.AX income_statement (annual, 2021-06-30) — Selling General And Administration: 265437.00
AYT.AX balance_sheet (annual, 2021-06-30) — Share Issued: 561078103.00
AYT.AX balance_sheet (annual, 2021-06-30) — Stockholders Equity: 8357008.00
AYT.AX balance_sheet (annual, 2021-06-30) — Tangible Book Value: 8357008.00
AYT.AX income_statement (annual, 2021-06-30) — Tax Effect Of Unusual Items: 0.00
AYT.AX income_statement (annual, 2021-06-30) — Tax Provision: 0.00
AYT.AX income_statement (annual, 2021-06-30) — Tax Rate For Calcs: 0.00
AYT.AX balance_sheet (annual, 2021-06-30) — Total Assets: 8432871.00
AYT.AX balance_sheet (annual, 2021-06-30) — Total Capitalization: 8357008.00
AYT.AX balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: 8357008.00
AYT.AX balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 75863.00
AYT.AX balance_sheet (annual, 2021-06-30) — Total Non Current Assets: 6087581.00
AYT.AX balance_sheet (annual, 2021-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00